NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $278,000 | +5.7% | 4,149 | +31.9% | 0.06% | +5.0% |
| Q1 2022 | $263,000 | -67.2% | 3,146 | -70.6% | 0.06% | -57.4% |
| Q4 2021 | $802,000 | +202.6% | 10,694 | +345.4% | 0.14% | +88.0% |
| Q3 2021 | $265,000 | -76.8% | 2,401 | -72.0% | 0.08% | -67.1% |
| Q1 2021 | $1,143,000 | +83.8% | 8,575 | +84.4% | 0.23% | -3.8% |
| Q3 2020 | $622,000 | +6.9% | 4,650 | -54.0% | 0.24% | +62.3% |
| Q2 2020 | $582,000 | -2.3% | 10,100 | +34.4% | 0.15% | -7.6% |
| Q4 2019 | $596,000 | – | 7,517 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
| Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
| HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
| GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
| Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
| Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
| HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
| HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
| Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |